All‐cause mortality (between start of intervention and end of · preterm infants
Enteral zinc supplementation may leads to lower all‐cause mortality (between start of intervention and end of compared with no zinc supplementation (low certainty).
1 finding from 1 review
Neurodevelopmental disability at 18 to 24 months among survivors · preterm infants
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Bronchopulmonary dysplasia · preterm infants
Enteral zinc supplementation showed no clear difference in bronchopulmonary dysplasia compared with no zinc supplementation (low certainty).
1 finding from 1 review
Retinopathy of prematurity · preterm infants
Enteral zinc supplementation showed no clear difference in retinopathy of prematurity compared with no zinc supplementation (low certainty).
1 finding from 1 review
Bacterial sepsis · preterm infants
Enteral zinc supplementation showed no clear difference in bacterial sepsis compared with no zinc supplementation (moderate certainty).
1 finding from 1 review
Necrotising enterocolitis · preterm infants
Enteral zinc supplementation showed no clear difference in necrotising enterocolitis compared with no zinc supplementation (low certainty).
1 finding from 1 review
Growth · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes acute rejection episodes compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes mortality compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
1 finding from 1 review
Systemic inflammatory response syndrome ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Organ failure ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes systemic inflammatory response syndrome compared with control (very low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes organ failure compared with control (very low certainty).
1 finding from 1 review
Adverse events ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review